Varinder Kumar

Employment

• Mylan (India) Sr. Group Leader
  2023 - Present
• Mylan India Group Leader
  2021 - 2022
• Sun Pharma (India) Research Manager
  2018 - 2021

Education

• Bhupal Nobles University PhD
• Jawaharlal Nehru Technological University Hyderabad M.S.
• Punjabi University Department of Pharmaceutical Sciences and Drug Research B. Pharma
• Indian Statistical Institute Lean Six Sigma Green Belt

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• In Vitro Abuse-Deterrent Performance of a QbD-Optimized Metformin HCl Extended-Release Matrix Tablet: Resistance to Crushing, Extraction, Syringeability and Alcohol-Induced Dose Dumping
  International Journal of Drug Delivery Technology 2026 DOI: 10.25258/ijddt.16.3s.91
  +Save
• Screening of Polymer using a QbD-Based Approach to Develop an Abuse-Deterrent Extended-Release Formulation of Metformin Hydrochloride-Model Drug
  European Journal of Clinical Pharmacy 2026
  +Save
• Multiple-reaction monitoring (MRM) LC-MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits
  SCIENTIFIC REPORTS 2022 DOI: 10.1038/S41598-022-13389-6
  +Save
• composição de liberação prolongada estável, processo para a preparação da composição de liberação prolongada
  2018
  +Save
• Osmotic floating tablets
  2018
  +Save
• Application of Assumed IVIVC in Product Life Cycle Management: A Case Study of Trimetazidine Dihydrochloride Extended Release Tablet
  DOI: DOI: 10.4172/jbb.1000128
  +Save
• GASTRORETENTIVE DOSAGE SYSTEM AND PROCESS OF PREPARATION THEREOF
  +Save
• Gastroretentive tablets
  +Save
• IVIVC from theory to application- Development of once daily extended release formulation of Trimetazidine di HCl using IVIVC
  +Save
• Osmotic Floating Tablets
  +Save